CMS Mulls Opposition to Downsizing Part D Protected Drug Classes - Targeted Oncology

CMS Mulls Opposition to Downsizing Part D Protected Drug Classes  Targeted OncologyThe healthcare community is still awaiting a response from the Centers for Medicare & Medicaid Services (CMS) to the opposition of the agency's proposal to ...